Hercules Welcomes New Board Member
Vancouver BC, October 25th, 2024 - Hercules Resources Corp., (CSE: HERC) (“Hercules” or the “Company”), is pleased to announce the appointment of Jason Robert Hawkins to its Board of Directors. Mr. Hawkins will act as an independent Director.
Mr. Hawkins has 25+ years of capital markets experience in both investment and merchant banking. Mr. Hawkins began his career as a technology and telecom investment banker before starting his own EMD. Over the course of his career Mr. Hawkins has raised seed to late-stage financing for companies in the mining, oil and gas, technology and healthcare sectors. Mr. Hawkins has financed numerous companies in the mining and oil and gas sectors with a focus on technologies and companies that leverage off the transition to “green” energy. Amongst his recent non-mining related ventures Mr. Hawkins co-founded and financed iUvo Therapeutics, a fully licensed GMP/GDP pharmaceutical importer and manufacturer headquartered in Germany and sits on the Board of Directors of InStatin Inc. a biopharma company specializing in novel inhaled therapies for the treatment of lung disease. Mr. Hawkins holds a B.Com (Honours) from Queen’s University.
Hercules welcomes Mr. Hawkins to the Board and looks forward to a long and supportive tenure.
About Hercules:
Hercules is a Canadian resource exploration company engaged in the acquisition, exploration and development of high potential mineral assets with the aim to develop concessions into production.
The company is dedicated to delivering value to its stakeholders through innovation, operational excellence, and sustainable practices. For more information, visit www.herculesresourcescorp.com.
Michael Smith, President, and Chief Executive Officer [email protected] (855) 791-GOLD (4653)
The information in this news release includes certain information and statements about management's view of future events, expectations, plans, and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and because of a variety of factors, the actual results, expectations, achievements, or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the Company’s proposed use of the proceeds of its offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether because of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements, or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.